174 related articles for article (PubMed ID: 19067320)
1. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Goldstein RB; Storch EA; Lehmkuhl H; Geffken GR; Goodman WK; Murphy TK
Depress Anxiety; 2009; 26(1):E23-5. PubMed ID: 19067320
[TBL] [Abstract][Full Text] [Related]
2. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
[TBL] [Abstract][Full Text] [Related]
4. Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies.
Taormina SP; Galloway MP; Rosenberg DR
J Dev Behav Pediatr; 2016; 37(6):491-5. PubMed ID: 27011005
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
Francobandiera G
J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
[No Abstract] [Full Text] [Related]
6. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
7. Urinary retention with sertraline, haloperidol, and clonazepam combination.
Benazzi F
Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
[No Abstract] [Full Text] [Related]
8. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
Bloch MH; Storch EA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
[TBL] [Abstract][Full Text] [Related]
9. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.
Reid AM; McNamara JP; Murphy TK; Guzick AG; Storch EA; Goodman WK; Geffken GR; Bussing R
J Psychiatr Res; 2015 Dec; 71():140-7. PubMed ID: 26495770
[TBL] [Abstract][Full Text] [Related]
10. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Párraga HC; Párraga MI; Harris DK
Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
13. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
15. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients.
Storch EA; Bagner DM; Geffken GR; Adkins JW; Murphy TK; Goodman WK
Depress Anxiety; 2007; 24(6):375-81. PubMed ID: 17044015
[TBL] [Abstract][Full Text] [Related]
16. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
Vloet TD; Simons M; Herpertz-Dahlmann B
Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study.
Gabriel A; Violato C
Atten Defic Hyperact Disord; 2011 Dec; 3(4):319-26. PubMed ID: 21833565
[TBL] [Abstract][Full Text] [Related]
18. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
Ressler KJ; Rothbaum BO
JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
[No Abstract] [Full Text] [Related]
19. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.
Sun TF; Lin PY; Wu CK
Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder in Tourette syndrome.
Goodman WK; Storch EA; Geffken GR; Murphy TK
J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
